← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Atorvastatin-Calcium-Trihydrat (Ph.Eur.) currently has availability issues reported in 2 European registers: Germany, Greece.
Shortage ATC C10AA05 · also listed as: Atorvastatin-Calcium-Trihydrat (Ph.Eur.) · data refreshed 11 September 2026
As of 11 September 2026, 2 of the 9 tracked registers list current availability issues for Atorvastatin-Calcium-Trihydrat (Ph.Eur.), covering 9 affected product presentations. The longest-running open report was filed in Germany on 2025-03-28 and has now been open for about 18 months. Where agencies state a cause, manufacturing problems lead with 4 of the 9 stated-cause reports, followed by unexpectedly high demand with 4. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-09-30. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 4 of the open reports were filed within the last 90 days. Registers in Germany indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Atorvastatin-Calcium-Trihydrat (Ph.Eur.) is coded C10AA05 — a medicine acting on the cardiovascular system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage ATORVASTATIN BASICS 30 mg Filmtabletten + 7 more productsATORVASTATIN BASICS 60 mg Filmtabletten ATORVASTATIN BASICS 80 mg Filmtabletten Atorvastatin Aristo 80 mg Filmtabletten Atorvastatin Micro Labs 10 mg Filmtabletten Atorvastatin Micro Labs 20 mg Filmtabletten Atorvastatin Micro Labs 30 mg Filmtabletten Atorvastatin PUREN 40 mg Filmtabletten | 2025-03-28 | 2026-12-31 | Probleme beim Wirkstoffhersteller Alternatives: N/A | register ↗ |
| 🇬🇷 Greece | Limited availability NELIBAT F.C.TAB 40MG/TAB BTx30 (BLIST 3x10) | 2026-04-01 | 2026-08-31 | Καθυστέρηση παράδοσης Εναλλακτικά άλλα σκευάσματα της ίδιας δραστικής, | register ↗ |
Every individual register entry for Atorvastatin-Calcium-Trihydrat (Ph.Eur.) in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇩🇪 DE | Atorvastatin Micro Labs 20 mg Filmtabletten | Shortage | 2026-08-19 | 2026-10-16 | Erhöhte Nachfrage |
| 🇩🇪 DE | Atorvastatin Micro Labs 30 mg Filmtabletten | Shortage | 2026-08-18 | 2026-10-16 | Erhöhte Nachfrage |
| 🇩🇪 DE | Atorvastatin Micro Labs 10 mg Filmtabletten | Shortage | 2026-08-17 | 2026-10-16 | Erhöhte Nachfrage |
| 🇩🇪 DE | Atorvastatin PUREN 40 mg Filmtabletten | Shortage | 2026-06-22 | 2026-09-30 | Probleme in der Herstellung |
| 🇬🇷 GR | NELIBAT F.C.TAB 40MG/TAB BTx30 (BLIST 3x10) | Limited availability | 2026-04-01 | 2026-08-31 | Καθυστέρηση παράδοσης Εναλλακτικά άλλα σκευάσματα της ίδιας |
| 🇩🇪 DE | ATORVASTATIN BASICS 60 mg Filmtabletten | Shortage | 2026-03-05 | 2026-12-31 | Probleme beim Wirkstoffhersteller |
| 🇩🇪 DE | ATORVASTATIN BASICS 30 mg Filmtabletten | Shortage | 2025-08-04 | 2026-12-31 | Probleme beim Wirkstoffhersteller |
| 🇩🇪 DE | ATORVASTATIN BASICS 80 mg Filmtabletten | Shortage | 2025-06-13 | 2026-12-31 | Probleme beim Wirkstoffhersteller |
| 🇩🇪 DE | Atorvastatin Aristo 80 mg Filmtabletten | Shortage | 2025-03-28 | 2026-12-01 | Erhöhte Nachfrage |
Yes. As of 11 September 2026, availability issues are reported in: Germany, Greece. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-30 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
8 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Atorvastatin-Calcium-Trihydrat (Ph.Eur.): BfArM (Germany), EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Atorvastatin-Calcium-Trihydrat (Ph.Eur.) — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/atorvastatin-calcium-trihydrat-ph-eur/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Atorvastatin-Calcium-Trihydrat (Ph.Eur.) availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/atorvastatin-calcium-trihydrat-ph-eur/">Atorvastatin-Calcium-Trihydrat (Ph.Eur.) shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>